1,330
Participants
Start Date
January 12, 2020
Primary Completion Date
July 20, 2021
Study Completion Date
July 20, 2021
Molbio Truenat™ HCV assay (the investigational product)
The Molbio Truenat™ HCV assay (the investigational product) is a quantitative chip-based Real Time Reverse Transcription Polymerase Chain Reaction (qRT-PCR) tests for the detection of HCV genomic RNA from human whole blood, EDTA plasma and serum. The Truenat™ HCV assay runs on the Truelab™ Uno, Truelab™ Duo or Truelab™ Quadro Dx. Results of testing by Truenat™ HCV assay will not be used to make any clinical decisions, and should not be communicated to study participants.
Abbott RealTime HCV assay
Plasma specimens will be also tested on Abbott RealTime HCV assay that is approved for HCV diagnostics use by countries' authorities. Only the results of Abbott RealTime HCV assay may be used to make clinical decisions.
Aarhus University Hospital, Aarhus
HIV-NAT Thai Red Cross AIDS Research Centre, Bangkok
St Paul's Hospital Millennium Medical College, Addis Ababa
National Centre for Diseases Control, Tbilisi
International Charitable Foundation Alliance for Public Health, Kyiv
Foundation for Innovative New Diagnostics, Switzerland
OTHER